Behçet's syndrome: Response to infliximab after failure of etanercept [15]

Rheumatology

Volumn 41, Issue 10, 2002, Pages 1213-1214

  Estrach, C ^a   Mpofu, S ^a   Moots, R J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; COLCHICINE; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; THALIDOMIDE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTHRALGIA; BEHCET DISEASE; CASE REPORT; CAUCASIAN; CLINICAL FEATURE; DRUG INFUSION; DRUG RESPONSE; ERYTHEMA NODOSUM; FEMALE; GENITAL ULCER; HUMAN; IRITIS; LETTER; PRIORITY JOURNAL; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036797056     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/41.10.1213-c     Document Type: Letter

References (4)

1. Rozenbaum M, Rosner I, Portnoy E. Remission of Behcet's syndrome with TNF-α blocking treatment. Ann Rheum Dis 2002;61:283-4.
2. Robertson LP, Hickling P. Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab. Rheumatology 2001;40:473-4.
3. Sfikakis PP, Theodossiadis PG, Katsiari CG. Effect of infliximab, on sight-threatening panuveitis in Behcet's disease. Lancet 2001; 358:295-96.
4. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli. Cytokines in Behcet's disease. J Rheumatol 1996;23:321-2.